title: Nicotine withdrawal.
abstract: An aversive abstinence syndrome manifests 4-24 h following cessation of chronic use of nicotine-containing products. Symptoms peak on approximately the 3rd day and taper off over the course of the following 3-4 weeks. While the severity of withdrawal symptoms is largely determined by how nicotine is consumed, certain short nucleotide polymorphisms (SNPs) have been shown to predispose individuals to consume larger amounts of nicotine more frequently--as well as to more severe symptoms of withdrawal when trying to quit. Additionally, rodent behavioral models and transgenic mouse models have revealed that specific nicotinic acetylcholine receptor (nAChR) subunits, cellular components, and neuronal circuits are critical to the expression of withdrawal symptoms. Consequently, by continuing to map neuronal circuits and nAChR subpopulations that underlie the nicotine withdrawal syndrome--and by continuing to enumerate genes that predispose carriers to nicotine addiction and exacerbated withdrawal symptoms--it will be possible to pursue personalized therapeutics that more effectively treat nicotine addiction.
authors: Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.
authors: Ian
authors: I
authors: McLaughlin
authors: John A
authors: JA
authors: Dani
authors: Mariella
authors: M
authors: De Biasi
mesh_terms: D000818:Animals; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology; D006801:Humans; D009538:Nicotine / Q000494:pharmacology*; D011978:Receptors, Nicotinic / Q000378:metabolism*; D013375:Substance Withdrawal Syndrome / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology
chemical_list: D011978:Receptors, Nicotinic; D009538:Nicotine
references: Neuropsychopharmacology. 2008 Aug;33(9):2158-66
references: 18033235
references: PLoS One. 2013 Nov 15;8(11):e79700
references: 24260284
references: J Neurosci. 2004 Nov 10;24(45):10035-9
references: 15537871
references: Addiction. 2014 Jan;109(1):128-137
references: 24033696
references: Hum Mol Genet. 2008 Sep 15;17(18):2834-48
references: 18593715
references: Cold Spring Harb Perspect Med. 2013 Jun 01;3(6):
references: 23732854
references: J Neurochem. 2008 Jan;104(2):446-56
references: 17961152
references: J Pharmacol Exp Ther. 2009 Nov;331(2):547-54
references: 19644040
references: Psychopharmacology (Berl). 2013 Sep;229(1):133-40
references: 23591603
references: J Neurochem. 1988 Apr;50(4):1243-7
references: 3346676
references: Neuropsychopharmacology. 2011 Apr;36(5):1021-32
references: 21289604
references: J Biol Chem. 1998 Oct 30;273(44):28721-32
references: 9786868
references: Neuron. 2009 Mar 12;61(5):786-800
references: 19285474
references: Trends Neurosci. 1996 May;19(5):181-2; discussion 188-9
references: 8723201
references: Prog Neurobiol. 2008 Apr;84(4):329-42
references: 18242816
references: Pharmacol Biochem Behav. 2001 Dec;70(4):531-49
references: 11796152
references: Pharmacogenomics J. 2007 Aug;7(4):266-74
references: 17189962
references: Eur J Haematol. 1989 Jan;42(1):96-8
references: 2914600
references: J Neurosci. 1999 Jun 15;19(12):4804-14
references: 10366615
references: Psychopharmacology (Berl). 2002 Oct;163(3-4):362-80
references: 12373437
references: Hum Mol Genet. 2012 Feb 1;21(3):647-55
references: 22042774
references: Psychopharmacology (Berl). 2005 Mar;178(2-3):183-92
references: 15365686
references: J Comp Neurol. 2009 Apr 20;513(6):597-621
references: 19235223
references: Nature. 2011 Mar 31;471(7340):597-601
references: 21278726
references: J Neurobiol. 2002 Dec;53(4):457-78
references: 12436413
references: Am J Med Genet B Neuropsychiatr Genet. 2009 Oct 5;150B(7):950-9
references: 19180564
references: Hum Genet. 2014 May;133(5):575-86
references: 24253422
references: Nicotine Tob Res. 2003 Apr;5(2):245-54
references: 12745498
references: Neuropharmacology. 2014 Apr;79:715-25
references: 24467848
references: Curr Biol. 2013 Dec 2;23(23):2327-35
references: 24239118
references: Neuron. 2011 Jul 14;71(1):9-34
references: 21745635
references: Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17198-203
references: 17921249
references: Genes Brain Behav. 2010 Oct;9(7):722-31
references: 20528956
references: J Pharmacol Exp Ther. 2008 Apr;325(1):302-12
references: 18184829
references: J Addict Res Ther. 2013 Apr 23;Suppl 6:007
references: 24619539
references: J Neurosci. 2003 Jul 16;23(15):6255-63
references: 12867510
references: Psychol Med. 2006 Jul;36(7):963-72
references: 16749946
references: Drug Alcohol Depend. 2000 Feb 1;58(1-2):93-102
references: 10669059
references: Front Hum Neurosci. 2014 Jan 17;7:931
references: 24478666
references: J Gen Physiol. 2014 Jan;143(1):51-66
references: 24378908
references: J Neurosci. 2005 Sep 21;25(38):8708-13
references: 16177040
references: J Neurosci. 2011 Aug 10;31(32):11457-71
references: 21832176
references: Hum Genet. 2008 Mar;123(2):119-31
references: 18205015
references: J Neurosci. 2003 Dec 3;23(35):11045-53
references: 14657161
references: Ann Hum Genet. 2000 Sep;64(Pt 5):383-90
references: 11281276
references: Neuropharmacology. 2007 Jan;52(1):215-27
references: 16919687
references: Mol Psychiatry. 2014 Aug;19(8):930-6
references: 24296975
references: Eur Neuropsychopharmacol. 2009 Aug;19(8):551-61
references: 19278836
references: Neuropharmacology. 2013 Jul;70:228-35
references: 23416040
references: ILAR J. 2006;47(2):124-31
references: 16547369
references: J Neurosci. 2009 Mar 11;29(10):3014-8
references: 19279237
references: Psychol Med. 2004 Jul;34(5):865-79
references: 15500307
references: Clin Chest Med. 2014 Mar;35(1):165-76
references: 24507844
references: Psychopharmacology (Berl). 2001 Aug;157(1):105-10
references: 11512050
references: Pharmacol Rev. 2011 Jun;63(2):291-315
references: 21415127
references: Neuron. 1996 May;16(5):905-8
references: 8630247
references: Mol Pharmacol. 2006 Oct;70(4):1358-68
references: 16835356
references: J Neurophysiol. 2010 Jul;104(1):403-13
references: 20445035
references: Pharmacogenomics J. 2006 Mar-Apr;6(2):115-9
references: 16402086
references: Pharmacol Biochem Behav. 2009 Feb;91(4):481-8
references: 19121334
references: Biochem Pharmacol. 2007 Oct 15;74(8):1235-46
references: 17825262
references: Biochem Pharmacol. 2011 Oct 15;82(8):996-1007
references: 21782803
references: BMC Genet. 2007 Apr 03;8:10
references: 17407593
references: Arch Gen Psychiatry. 2012 Aug;69(8):854-60
references: 22868939
references: J Neurosci. 2014 Mar 19;34(12):4273-84
references: 24647947
references: J Pharmacol Exp Ther. 1983 Sep;226(3):817-25
references: 6887012
references: J Neurosci. 2010 Jul 7;30(27):9241-52
references: 20610759
references: Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12493-7
references: 11050152
references: Neuropsychopharmacology. 2012 Feb;37(3):641-50
references: 22048466
references: Cancer Epidemiol Biomarkers Prev. 2009 Oct;18(10):2608-12
references: 19755656
references: Nat Genet. 2010 May;42(5):441-7
references: 20418890
references: Annu Rev Psychol. 2005;56:207-34
references: 15709934
references: Am J Med. 2008 Apr;121(4 Suppl 1):S3-10
references: 18342164
references: J Pharmacol Exp Ther. 2010 Jul;334(1):137-46
references: 20400469
references: Behav Genet. 2012 May;42(3):423-36
references: 22009521
references: Pharmacol Biochem Behav. 2007 May;87(1):146-57
references: 17509676
references: Psychol Med. 2005 Mar;35(3):409-19
references: 15841876
references: Neuropsychopharmacology. 2008 Feb;33(3):588-98
references: 17443125
references: Tob Control. 2002 Jun;11(2):119-24
references: 12035004
references: Psychopharmacology (Berl). 2010 Jul;210(4):453-69
references: 20414766
references: Neuropharmacology. 2014 Feb;77:217-23
references: 24107576
references: Exp Biol Med (Maywood). 2008 Aug;233(8):917-29
references: 18480414
references: Arch Gen Psychiatry. 2006 Aug;63(8):907-15
references: 16894067
references: Biochem Pharmacol. 2009 Oct 1;78(7):756-65
references: 19540212
references: J Neurosci. 1998 Nov 1;18(21):8571-9
references: 9786965
references: J Pharmacol Exp Ther. 2012 Aug;342(2):327-34
references: 22550286
references: Neuropharmacology. 2012 Apr;62(5-6):2118-25
references: 22285742
references: Front Behav Neurosci. 2010 Jun 14;4:29
references: 20676234
references: J Neurosci. 2009 May 27;29(21):6883-96
references: 19474315
references: Nicotine Tob Res. 2014 Jul;16(7):923-30
references: 24583363
references: Neuropharmacology. 1998 Apr-May;37(4-5):421-9
references: 9704983
references: Science. 2004 Mar 26;303(5666):2040-2
references: 15044807
references: Am J Med Genet B Neuropsychiatr Genet. 2011 Apr;156B(3):275-84
references: 21268243
references: Psychopharmacology (Berl). 1997 Jul;132(2):107-24
references: 9266608
references: Neuropharmacology. 2010 Jun;58(7):1054-66
references: 20114055
references: J Mol Neurosci. 2010 Jan;40(1-2):177-84
references: 19693707
references: Curr Drug Abuse Rev. 2008 Jan;1(1):9-19
references: 19630701
references: Nat Genet. 2010 May;42(5):448-53
references: 20418888
references: Trends Pharmacol Sci. 2002 May;23(5):238-45
references: 12008002
references: J Neurophysiol. 2007 Feb;97(2):1621-32
references: 17122317
references: Proc Natl Acad Sci U S A. 1999 May 11;96(10):5746-51
references: 10318955
references: Curr Drug Targets CNS Neurol Disord. 2002 Aug;1(4):359-85
references: 12769610
references: J Pharmacol Exp Ther. 2007 Jul;322(1):306-15
references: 17446303
references: Psychopharmacology (Berl). 2013 Aug 20;:
references: 23958943
references: Biol Psychiatry. 2012 Feb 1;71(3):184-91
references: 21872847
references: Neuron. 2011 May 12;70(3):522-35
references: 21555077
references: Psychopharmacology (Berl). 2005 Mar;178(2-3):211-22
references: 15338107
references: Naunyn Schmiedebergs Arch Pharmacol. 1998 Feb;357(2):176-82
references: 9521491
references: J Neurosci. 2009 Feb 18;29(7):2272-82
references: 19228980
references: J Biol Chem. 2004 Apr 30;279(18):18767-75
references: 14764595
references: Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):16446-50
references: 21930931
references: J Neurosci Methods. 2008 Jun 15;171(1):48-52
references: 18358538
references: J Neurosci. 2013 May 1;33(18):7728-41
references: 23637165
references: Neuropharmacology. 2007 Dec;53(7):863-9
references: 17920082
references: J Neurosci. 2006 Aug 23;26(34):8707-14
references: 16928859
references: Hum Genet. 2012 Jan 31;:
references: 22290489
references: Annu Rev Neurosci. 2011;34:105-30
references: 21438686
references: J Comp Neurol. 2005 Sep 26;490(3):270-94
references: 16082674
references: Am J Med Genet B Neuropsychiatr Genet. 2009 Jun 5;150B(4):453-66
references: 19259974
references: Neuron. 2008 Mar 27;57(6):809-18
references: 18367082
references: J Intern Med. 2014 Sep;276(3):201-14
references: 24605849
references: Mol Pharmacol. 2011 Jan;79(1):119-25
references: 20881005
references: Mol Pharmacol. 2003 May;63(5):1059-66
references: 12695534
references: J Gen Physiol. 2011 Jan;137(1):59-79
references: 21187334
references: Neurobiol Learn Mem. 2012 May;97(4):482-94
references: 22521799
references: Brain Struct Funct. 2008 Sep;213(1-2):43-61
references: 18651175
references: Refuat Hashinayim. 1985 Jul;3(3):3-12
references: 3864572
references: Annu Rev Psychol. 2008;59:29-53
references: 18154498
references: Nicotine Tob Res. 2009 Jul;11(7):785-96
references: 19436041
references: Brain Res. 1998 Jan 1;779(1-2):214-25
references: 9473676
references: Genes Brain Behav. 2009 Jun;8(4):398-406
references: 19220484
references: Biol Psychiatry. 2007 Sep 15;62(6):635-41
references: 17223085
references: Nicotine Tob Res. 2011 Jan;13(1):41-6
references: 21097981
references: Psychopharmacology (Berl). 1994 Jun;115(1-2):180-4
references: 7862893